Aktieanalys

Sedana Medical: Updated FDA timeline and Q2 preview - Redeye

{newsItem.title}

Redeye Publicerad: 13 Jul 2023 08:24

Redeye lowers its fair value range following the updated FDA timeline, which will likely hold the share back from any sustainable positive momentum for some time. Moreover, we provide our Q2 2023 preview for the report due on July 21.

Länk till analysen i sin helhet: https://www.redeye.se/research/921319/sedana-medical-updated-fda-timeline-and-q2-preview?utm_source=finwire&utm_medium=RSS

Nyheter om Sedana Medical

Läses av andra just nu

Om aktien Sedana Medical

Senaste nytt